Oracle Data Integrator 12.2.1.4.0/14.1.2.0.0 Studio privileges management
| CVSS Meta Temp Score | Current Exploit Price (≈) | CTI Interest Score |
|---|---|---|
| 5.3 | $5k-$25k | 0.64 |
Summary
A vulnerability classified as problematic has been found in Oracle Data Integrator 12.2.1.4.0/14.1.2.0.0. This impacts an unknown function of the component Studio. This manipulation causes privileges management. The identification of this vulnerability is CVE-2026-60625. The attack can only be executed locally. There is no exploit available.
Details
A vulnerability classified as problematic was found in Oracle Data Integrator 12.2.1.4.0/14.1.2.0.0. Affected by this vulnerability is some unknown processing of the component Studio. The manipulation with an unknown input leads to a privileges management vulnerability. The CWE definition for the vulnerability is CWE-269. The product does not properly assign, modify, track, or check privileges for an actor, creating an unintended sphere of control for that actor. As an impact it is known to affect confidentiality, integrity, and availability. The summary by CVE is:
Vulnerability in the Oracle Data Integrator product of Oracle Fusion Middleware (component: Studio). Supported versions that are affected are 12.2.1.4.0 and 14.1.2.0.0. Easily exploitable vulnerability allows low privileged attacker with logon to the infrastructure where Oracle Data Integrator executes to compromise Oracle Data Integrator. Successful attacks of this vulnerability can result in takeover of Oracle Data Integrator. CVSS 3.1 Base Score 7.8 (Confidentiality, Integrity and Availability impacts). CVSS Vector: (CVSS:3.1/AV:L/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H).
The advisory is shared at oracle.com. This vulnerability is known as CVE-2026-60625 since 07/08/2026. The exploitation appears to be easy. An attack has to be approached locally. Neither technical details nor an exploit are publicly available. The price for an exploit might be around USD $5k-$25k at the moment (estimation calculated on 07/22/2026). MITRE ATT&CK project uses the attack technique T1068 for this issue.
There is no information about possible countermeasures known. It may be suggested to replace the affected object with an alternative product.
If you want to get the best quality for vulnerability data then you always have to consider VulDB.
Product
Vendor
Name
Version
License
Website
- Vendor: https://www.oracle.com
CPE 2.3
CPE 2.2
CVSSv4
VulDB Vector: 🔒VulDB Reliability: 🔍
CVSSv3
VulDB Meta Base Score: 5.3VulDB Meta Temp Score: 5.3
VulDB Base Score: 5.3
VulDB Temp Score: 5.3
VulDB Vector: 🔒
VulDB Reliability: 🔍
CVSSv2
| AV | AC | Au | C | I | A |
|---|---|---|---|---|---|
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| Vector | Complexity | Authentication | Confidentiality | Integrity | Availability |
|---|---|---|---|---|---|
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
VulDB Base Score: 🔒
VulDB Temp Score: 🔒
VulDB Reliability: 🔍
Exploiting
Class: Privileges managementCWE: CWE-269 / CWE-266
CAPEC: 🔒
ATT&CK: 🔒
Physical: Partially
Local: Yes
Remote: No
Availability: 🔒
Status: Not defined
Price Prediction: 🔍
Current Price Estimation: 🔒
| 0-Day | Unlock | Unlock | Unlock | Unlock |
|---|---|---|---|---|
| Today | Unlock | Unlock | Unlock | Unlock |
Threat Intelligence
Interest: 🔍Active Actors: 🔍
Active APT Groups: 🔍
Countermeasures
Recommended: no mitigation knownStatus: 🔍
0-Day Time: 🔒
Timeline
07/08/2026 CVE reserved07/22/2026 Advisory disclosed
07/22/2026 VulDB entry created
07/22/2026 VulDB entry last update
Sources
Vendor: oracle.comAdvisory: oracle.com
Status: Confirmed
CVE: CVE-2026-60625 (🔒)
GCVE (CVE): GCVE-0-2026-60625
GCVE (VulDB): GCVE-100-381709
Entry
Created: 07/22/2026 05:10Changes: 07/22/2026 05:10 (52)
Complete: 🔍
Cache ID: 216::103
If you want to get the best quality for vulnerability data then you always have to consider VulDB.
No comments yet. Languages: en.
Please log in to comment.